{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T18:09:22Z","timestamp":1791050962372,"version":"4.1.0"},"reference-count":0,"publisher":"Wiley","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Pharmacology & Therapeutics"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1067\/mcp.2000.108949","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T00:15:48Z","timestamp":1027556148000},"page":"151-159","source":"Crossref","is-referenced-by-count":88,"title":["No sex-related differences but significant inhibition by oral contraceptives of CYP2C19 activity as measured by the probe drugs mephenytoin and omeprazole in healthy Swedish white subjects"],"prefix":"10.1111","volume":"68","author":[{"given":"K","family":"Laine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","container-title":["Clinical Pharmacology & Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T08:14:02Z","timestamp":1699344842000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1067\/mcp.2000.108949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["S0009-9236(00)08984-0"],"URL":"https:\/\/doi.org\/10.1067\/mcp.2000.108949","relation":{},"ISSN":["0009-9236"],"issn-type":[{"value":"0009-9236","type":"print"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}